Correction and Retraction Policy
All contributions that are selected for peer review are sent to two or more independent reviewers. We use double-blind peer review. Papers may be rejected without external review at the Editor’s discretion.
Chinese Journal of Evidence-based Medicine provides immediate open access to its content on the principle of making research freely available to the public to support a greater global knowledge exchange.
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are double-blind peer reviewed by two anonymous reviewers and the Editors. Final acceptance or rejection rests with the Editors, who reserve the right to refuse any material for publication.
Manuscripts are assigned sequentially to Associate Editors. An Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors.
The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised or is rejected. Minor revisions are expected to be returned within four weeks of decision; major revisions within three months. Manuscripts not revised within these time periods are subject to withdrawal from consideration for publication unless the authors can provide extenuating circumstances.
A number of manuscripts will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editor find it inappropriate for publication in the Journal.
The Editor-in-Chief’s decision is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief.
If manuscripts are submitted by an Editor, they will be assigned to and processed by other Editors to avoid conflicts of interest.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editors and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.
CJEBM employs a plagiarism detection system. By submitting your manuscript to this journal, you accept that your manuscript may be screened for plagiarism against previously published works.
At the end of the text, under a subheading 'Conflict of interest statement' all authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
If the article submitted to the Chinese Journal of Evidence-based Medicine is a clinical study, it should be indicated whether the clinical study conforms to the principles stipulated in the Declaration of Helsinki(DoH), whether it has been approved by the Medical Ethics Committee (if approved, the name of the committee and the approval number should be provided),and whether the patients have given their informed consent; if the article is a clinical trial research, it is recommended that the Chinese clinical trial registration number be provided. Animal experimental research should indicate whether it has been approved by the animal welfare ethics committee, and provide the name of the committee and the approval number as well as the license number of the animal.
Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement''.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
We recognize our responsibility to correct errors. Content published online is final and cannot be amended. The online version is part of the published record; therefore the original version must be preserved and changes to the paper should be made as a formal correction. If an error is noticed after online publication an HTML (or full-text) version of the correction will be created and linked to the original article.